COVID-19 is a global pandemic impacting the daily living of millions. As variants of the virus
evolve, a complete comprehension of the disease and drug targets becomes a decisive …

Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …

Abstract Novel coronavirus (SARS–CoV–2), turned out to be a global pandemic with
unstoppable morbidity and mortality rate. However, till date there is no effective treatment …

The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has heavily challenged the
global healthcare system. Despite the vaccination programs, the new virus variants are …

The disease caused by SARS-CoV2, covid-19, rapidly spreads worldwide, causing the
greatest threat to global public health in the last 100 years. This scenario has become …

SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …

Understanding the mechanism of SARS‐CoV‐2 infection and identifying potential
therapeutics are global imperatives. Using a quantitative systems pharmacology approach …

Background The recent global pandemic has placed a high priority on identifying drugs to
prevent or lessen clinical infection of severe acute respiratory syndrome coronavirus 2 …

The recent outbreak of coronavirus disease 2019 (COVID-19) by SARS-CoV-2 has led to
uptodate 24.3 M cases and 0.8 M deaths. It is thus in urgent need to rationalize potential …